The purpose of the present study was to test whether the addition of cisatracurium in combination with propofol and sevoflurane would result in a change in doses of used anesthetic drugs. Ten dogs (Group A) undergoing elective unilateral mastectomy surgery were included in the study. To induce and maintain anesthesia, subjects received propofol and sevoflurane at varying doses; analgesia was performed with remifentanil. After three months, the same subjects (Group B) underwent contralateral mastectomy and received the same anesthetic protocol with the addition of cisatracurium at a dosage of 0.2 mg/kg⁻¹. The following parameters were monitored during anesthe sia: heart rate, systolic blood pressure, end-tidal CO₂, oxygen saturation, halogenate requirement, and rectal temperature at baseline (T⁰), induction (T¹), 5 (T⁵), 10 (T¹⁰), 15 (T¹⁵), 20 (T²⁰), 25 (T²⁵), 30 (T³⁰), and 35 (T³⁵) time points. In Group A, halogenate requirement was reduced at all the time points other than T1 (p < 0.001); in Group B, the percentage of halogenate requirement was already reduced at T¹ and remained constant during the experimental period, showing no significant intragroup differences. The dose requirements of sevoflurane and propofol varied significantly between the two groups, with significantly lower dosages in the Group B (the cisatracurium-treated group). Moreover, patients treated with cisatracurium showed a stable anesthetic plan. The nondepolarizing-muscle-relaxant cisatracurium besylate could be considered a useful adjunct to anesthetic protocols.

Effects of cisatracurium in sevoflurane and propofol requirements in dog-undergoing-mastectomy surgery

Interlandi, Claudia
Primo
;
Di Pietro, Simona
Secondo
;
Costa, Giovanna L.
;
Spadola, Filippo;Iannelli, Nicola M.;Macri', Francesco
Ultimo
2022-01-01

Abstract

The purpose of the present study was to test whether the addition of cisatracurium in combination with propofol and sevoflurane would result in a change in doses of used anesthetic drugs. Ten dogs (Group A) undergoing elective unilateral mastectomy surgery were included in the study. To induce and maintain anesthesia, subjects received propofol and sevoflurane at varying doses; analgesia was performed with remifentanil. After three months, the same subjects (Group B) underwent contralateral mastectomy and received the same anesthetic protocol with the addition of cisatracurium at a dosage of 0.2 mg/kg⁻¹. The following parameters were monitored during anesthe sia: heart rate, systolic blood pressure, end-tidal CO₂, oxygen saturation, halogenate requirement, and rectal temperature at baseline (T⁰), induction (T¹), 5 (T⁵), 10 (T¹⁰), 15 (T¹⁵), 20 (T²⁰), 25 (T²⁵), 30 (T³⁰), and 35 (T³⁵) time points. In Group A, halogenate requirement was reduced at all the time points other than T1 (p < 0.001); in Group B, the percentage of halogenate requirement was already reduced at T¹ and remained constant during the experimental period, showing no significant intragroup differences. The dose requirements of sevoflurane and propofol varied significantly between the two groups, with significantly lower dosages in the Group B (the cisatracurium-treated group). Moreover, patients treated with cisatracurium showed a stable anesthetic plan. The nondepolarizing-muscle-relaxant cisatracurium besylate could be considered a useful adjunct to anesthetic protocols.
2022
File in questo prodotto:
File Dimensione Formato  
animals-Sevo Propo12-03134.pdf

accesso aperto

Descrizione: Clinical Studies
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 272.41 kB
Formato Adobe PDF
272.41 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3244277
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact